ArticleDiabetes2018

Extending Remission and Reversing New-Onset Type 1 Diabetes by Targeted Ablation of Autoreactive T Cells.

Kaitlin R Carroll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.